Gene Expression Signature Differentiates Histology But Not Progression Status of Early-Stage NSCLC

Advances in molecular analyses based on high-throughput technologies can contribute to a more accurate classification of non–small cell lung cancer (NSCLC), as well as a better prediction of both the disease course and the efficacy of targeted therapies. Here we set out to analyze whether global gen...

Full description

Bibliographic Details
Main Authors: Radoslaw Charkiewicz, Jacek Niklinski, Jürgen Claesen, Anetta Sulewska, Miroslaw Kozlowski, Anna Michalska-Falkowska, Joanna Reszec, Marcin Moniuszko, Wojciech Naumnik, Wieslawa Niklinska
Format: Article
Language:English
Published: Elsevier 2017-06-01
Series:Translational Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523316302479